Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,691 annual reports · 4,011 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 110 of 641 · 7,691 filings

  • BuzzFeed (BZFD) FY2025 10-K risk factors
    59 risks11 new11 dropped11 reworded

    BuzzFeed faces substantial going concern doubt with $8.5 million in cash and rising net losses of $57.3 million.

    Filed Mar 16, 2026
  • Perspective Therapeutics (CATX) FY2025 10-K risk factors
    Risk factors section under review

    New international and multi-jurisdiction regulatory compliance risk includes fines, license suspension, price reductions, and criminal sanctions.

    Filed Mar 16, 2026
  • Capital Bancorp (CBNK) FY2025 10-K risk factors
    41 risks3 new1 dropped6 reworded

    Capital Bancorp added risks regarding renewable energy tax credit changes, an internal control material weakness, and AI adoption. Management updated disclosures for the 2025 government shutdown, reduced subordinated note debt figures, and shifting regulatory priorities across presidential administrations.

    Filed Mar 16, 2026
  • Coya Therapeutics (COYA) FY2025 10-K risk factors
    100 risks4 new6 dropped8 reworded

    Coya Therapeutics discloses cash runway into the second half of 2027 with $46.8 million as of December 31, 2025 plus an $11.1 million January 2026 offering. Net loss increased to $21.2 million for 2025, bringing the accumulated deficit to $62.0 million. Supply chain and manufacturing dependencies for COYA 201, COYA 206, and COYA 301 are newly detailed.

    Filed Mar 16, 2026
  • Consumer Portfolio Services (CPSS) FY2025 10-K risk factors
    32 risks1 new4 reworded

    The company added a risk regarding artificial intelligence adoption in its auto finance operations. Insider ownership of common stock dropped from 61% to 56%. Dealer concentration decreased from 2% to 1.5% max share.

    Filed Mar 16, 2026
  • Contango Silver & Gold (CTGO) FY2025 10-K risk factors
    38 risks8 new3 dropped11 reworded

    Contango entered a merger agreement with Dolly Varden Silver, adding regional and commodity expansion risks. High gold prices inflate mining exploration costs and contract equipment demand in Alaska. Reliance on CEO Rick Van Nieuwenhuyse and Peak Gold JV funding dilution risks remain central.

    Filed Mar 16, 2026
  • CytomX Therapeutics (CTMX) FY2025 10-K risk factors
    83 risks11 new9 dropped21 reworded

    CytomX faces significant funding runway pressures, relying on $137.1 million to fund operations into the second quarter of 2027.

    Filed Mar 16, 2026
  • Cue Biopharma (CUE) FY2025 10-K risk factors
    74 risks16 new10 dropped19 reworded

    Cue Biopharma prioritized autoimmune programs, licensing CUE-501 to BI and CUE-100 series to IMSCP.

    Filed Mar 16, 2026
  • Consolidated Water (CWCO) FY2025 10-K risk factors
    23 risks5 new3 dropped4 reworded

    Cayman Islands retail water license and OfReg negotiations threaten operating income. Bahamas accounts receivable delinquency remains a primary cash flow concern.

    Filed Mar 16, 2026
  • Cypherpunk Technologies (CYPH) FY2025 10-K risk factors
    37 risks25 new14 dropped7 reworded

    The company shifted its business strategy toward a digital asset treasury, heavily investing in ZEC.

    Filed Mar 16, 2026
  • DocGo (DCGO) FY2025 10-K risk factors
    76 risks8 new4 dropped14 reworded

    DocGo reported a $196.4 million 2025 net loss, $183.8 million accumulated deficit, and a going-concern warning.

    Filed Mar 16, 2026
  • Dollar Tree (DLTR) FY2026 10-K risk factors
    32 risks6 new3 dropped15 reworded

    Dollar Tree completed the Family Dollar sale, shifting focus entirely to the standalone Dollar Tree banner and multi-price strategy.

    Filed Mar 16, 2026

Companies covered

4,011 companies

371 more under A